Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study

OBJECTIVES: We conducted a phase I/II prospective trial to determine whether stereotactic dose escalation to the dominant intra-prostatic nodule (DIN) up to 50 Gy incorporating a rectal balloon spacer is safe, does not affect patient quality of life, and preserves local control in patients with inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Cloitre, Minna, Valerio, Massimo, Mampuya, Ange, Rakauskas, Arnas, Berthold, Dominik, Tawadros, Thomas, Meuwly, Jean-Yves, Heym, Leonie, Duclos, Frederic, Vallet, Véronique, Zeverino, Michele, Jichlinski, Patrice, Prior, John, Roth, Beat, Bourhis, Jean, Herrera, Fernanda G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The British Institute of Radiology. 2023
Materias:
Full Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161910/
https://www.ncbi.nlm.nih.gov/pubmed/36745031
http://dx.doi.org/10.1259/bjr.20220803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161910/
https://www.ncbi.nlm.nih.gov/pubmed/36745031
http://dx.doi.org/10.1259/bjr.20220803

Ejemplares similares